Employment and Staff Costs - As of June 30, 2023, the Group employed 139 full-time employees, a decrease from 146 employees as of June 30, 2022[2] - Total staff costs for the Review Year amounted to approximately S$16.9 million, up from approximately S$12.2 million in 2022, reflecting a significant increase in personnel expenses[2] - The Group is committed to providing adequate job training and performance reviews to retain valuable employees[2] - The performance of the Group's employees is reviewed annually to ensure alignment with market conditions and individual contributions[2] Financial Performance - The Group's revenue for the review year was approximately S$13.4 million, with a gross profit of approximately S$4.5 million and a loss before taxation of approximately S$14.3 million[76] - The Group's revenue for the Review Year was approximately SGD 13.4 million, an increase of about SGD 3.4 million or 33.8% compared to approximately SGD 10.0 million for the year ended June 30, 2022[134] - For the review year, the Group's revenue was approximately S$13.4 million, representing an increase of approximately S$3.4 million, or 33.8%, compared to approximately S$10.0 million for the year ended 30 June 2022[167] Strategic Initiatives and Future Plans - The net proceeds from the Listing were approximately HK$74.0 million, intended for various applications including property acquisition, manpower strengthening, and marketing efforts[5] - The Group plans to use the Listing Net Proceeds for acquiring additional properties, recruiting more staff, and increasing marketing efforts, among other uses[6] - The Group aims to enhance its reserve for financing performance guarantees for customers as part of its strategic initiatives[5] - The Group's future plans include financing the acquisition of additional motor vehicles and machinery to support operational growth[5] - The Group aims to strengthen its market position in the medical and healthcare construction sectors in Singapore and diversify into financial technology (FinTech) areas[77] - The Group is well-positioned to face future challenges and competition, aiming to deliver satisfactory returns to shareholders[162] Corporate Governance - The company has adopted all mandatory disclosure requirements and code provisions of the Corporate Governance Code as its own corporate governance practices[48] - The Board is committed to achieving high standards in sustainability and accountability through effective corporate governance[51] - The company will continue to comply with the Corporate Governance Code to protect the best interests of the Group and its shareholders[49] - The Board will continuously review and improve corporate governance practices to ensure proper regulation of business activities and decision-making processes[52] - The company has a commitment to maintaining high standards of corporate governance to safeguard shareholder interests and enhance corporate value[48] - Any deviation from the Corporate Governance Code will be carefully considered and disclosed in interim and annual reports[49] Board Structure and Committees - The Board consists of three executive directors, two non-executive directors, and three independent non-executive directors, ensuring a diverse governance structure[91] - The Board has established three committees: Audit Committee, Remuneration Committee, and Nomination Committee, all chaired by independent non-executive directors[125] - The Company established the Nomination Committee, which comprises three Independent Non-Executive Directors (INEDs) and is chaired by Prof. Pong Kam Keung[131] - The Remuneration Committee reviewed and made recommendations on the Company's remuneration policy and structure, including the remuneration packages of Directors and senior management[132] - The Nomination Committee reviews the structure, size, and composition of the Board, assessing the skills and experience of its members[172] Audit and Compliance - During the Review Year, the Audit Committee reviewed the Group's accounting principles and practices, including the audited financial statements and compliance with the Corporate Governance Code[190] - The remuneration paid to the auditor for the annual audit fee was approximately S$226,063, with no fees for non-audit services during the Review Year[197] - The Company confirmed that there are no significant uncertainties regarding its ability to continue as a going concern[199] - The Company appointed Zhonghui Anda CPA Limited as its auditor effective from July 31, 2023, following the resignation of the previous auditor[199] Marketing and Business Development - The Group's marketing efforts are set to increase as part of its strategy to expand market presence[6] - The Company has established a comprehensive fintech service platform for various asset classes, including virtual assets and listed securities, since May 2021[100] - A competent FinTech team has been established to develop and manage trading systems, custody infrastructure, cybersecurity, market data analytics, compliance, anti-money laundering, and risk management[78] - The Group has applied for relevant regulatory licenses for virtual asset trading platform operations in Hong Kong to capture fast-growing FinTech business opportunities[78] Healthcare Sector Insights - The Minister of Health of Singapore announced plans to expand the network of polyclinics from 23 to 32 by 2030[76] - The Singapore government plans to expand its network to 32 polyclinics by 2030, increasing from the current 23, which is expected to drive demand for medical-related radiation shielding works[168] - The average waiting time for MRI scans in public hospitals is currently 3 months, indicating high demand for diagnostic imaging machines[168] - The Directors believe that the increasing demand for healthcare and elderly care services in Singapore will continue due to the aging population[168] - The Group's Engineering Business primarily focuses on integrated designs and building services for hospitals and clinics in Singapore[166]
HKE HOLDINGS(01726) - 2023 - 年度财报